Goldman Sachs Commodity Index Futures (GSCI)) (GD July 2024)/ XFTTGDCMEGLB / CME GLOBEX
GD| 18/06/2024 16:48:08 | Chg. +2.7000 | Bid22:28:14 | Ask22:28:14 | Open | High | Low | Previous Close |
|---|---|---|---|---|---|---|---|
| 581.1500USD | +0.47% | - | - | 580.1500 | 581.1500 | 580.0000 | 578.4500 |
GlobeNewswire
11/06
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
05/06
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...
GlobeNewswire
03/06
Goliath Mobilizes For 15,000 Meter Drill Program To Test Surebet Feeder Source Plus Three New High-G...
GlobeNewswire
03/06
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
01/06
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Gli...
GlobeNewswire
31/05
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
GlobeNewswire
30/05
Genius Metals Completes a High-Resolution MAG Survey on its Dissimieux Phosphate-Titanium-Rare Earth...
GlobeNewswire
30/05
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and P...
GlobeNewswire
28/05
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire
28/05
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
25/05
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...
GlobeNewswire
21/05
AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI3...
GlobeNewswire
09/05
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
01/05
COMSTOCK RESOURCES, INC. REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
GlobeNewswire
22/04
GDC Enhances TikTok Marketing for Small and Medium-sized Businesses with Comprehensive Service Suite
GlobeNewswire
18/04
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...
GlobeNewswire
17/04
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
Newsfile Corp
16/04
Appia Files NI 43-101 Technical Report on Maiden Indicated and Inferred Mineral Resource Estimate fo...
GlobeNewswire
16/04
AMD Expands Commercial AI PC Portfolio to Deliver Leadership Performance Across Professional Mobile ...
GlobeNewswire
15/04
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis...
